BCG+MM Trial: Adding mitomycin to BCG as adjuvant intravesical therapy for high-risk, non–muscle-invasive bladder cancer: a 2-stage, randomised phase 3 trial.
GA ID:
Agency:
National Health and Medical Research Council (NHMRC)
Publish Date:
21-Dec-2018
Category:
Medical Research
Grant Term:
1-Jan-2019
to
31-Dec-2023
Value (AUD):
$1,587,163.80
Recipient Name:
University of Sydney
Last Updated:
21-Dec-2018 10:04 am (ACT Local Time)